US Stock MarketDetailed Quotes
TBPH Theravance Biopharma
- 9.520
- -0.050-0.52%
Close Nov 15 16:00 ET
- 9.550
- +0.030+0.32%
Post 16:31 ET
468.14MMarket Cap-9242P/E (TTM)
9.620High9.250Low213.27KVolume9.620Open9.570Pre Close2.02MTurnover1.01%Turnover RatioLossP/E (Static)49.17MShares11.71052wk High2.52P/B200.17MFloat Cap7.44052wk Low--Dividend TTM21.03MShs Float124.866Historical High--Div YieldTTM3.87%Amplitude6.100Historical Low9.491Avg Price1Lot Size
Theravance Biopharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -31.82%91.36M | -42.62%96.08M | -58.56%99.98M | -68.72%102.43M | -68.72%102.43M | -72.47%134M | 26.05%167.45M | 63.55%241.26M | 88.79%327.48M | 88.79%327.48M |
| -Cash and cash equivalents | ---- | -56.11%46.35M | -71.31%53.84M | -86.74%39.55M | -86.74%39.55M | -82.87%71.69M | 20.97%105.6M | 98.87%187.67M | 231.45%298.17M | 231.45%298.17M |
| -Short-term investments | ---- | -19.60%49.73M | -13.91%46.14M | 114.52%62.88M | 114.52%62.88M | -8.75%62.32M | 35.77%61.86M | 0.84%53.6M | -64.90%29.31M | -64.90%29.31M |
| Receivables | -1.24%16.85M | -9.48%14.3M | 19.51%14.66M | 4.10%17.47M | 4.10%17.47M | 20.85%17.06M | 26.49%15.8M | -74.35%12.27M | -70.86%16.79M | -70.86%16.79M |
| -Accounts receivable | -1.24%16.85M | -9.48%14.3M | 19.51%14.66M | 4.10%17.47M | 4.10%17.47M | 20.85%17.06M | 26.49%15.8M | -0.06%12.27M | 19.34%16.79M | 19.34%16.79M |
| Prepaid assets | -63.46%597K | 170.28%2.65M | 36.88%2.09M | 34.70%2.04M | 34.70%2.04M | -38.22%1.63M | -57.64%979K | -67.86%1.52M | -85.23%1.51M | -85.23%1.51M |
| Other current assets | -14.66%7.68M | -19.20%6.28M | 20.51%7.57M | 51.04%11.6M | 51.04%11.6M | 10.69%9M | 9.84%7.78M | 38.29%6.28M | -10.27%7.68M | -10.27%7.68M |
| Total current assets | -27.96%116.48M | -37.86%119.31M | -52.44%124.29M | -62.22%133.54M | -62.22%133.54M | -68.40%161.69M | 24.09%192M | 27.71%261.34M | 41.46%353.46M | 41.46%353.46M |
| Non current assets | ||||||||||
| Net PPE | -20.79%37.12M | -16.77%39.96M | -14.08%44.08M | -12.78%45.36M | -12.78%45.36M | -9.66%46.86M | -10.51%48.01M | -2.43%51.31M | -2.52%52M | -2.52%52M |
| -Gross PPE | -20.79%37.12M | -16.77%39.96M | -14.08%44.08M | -21.10%66.94M | -21.10%66.94M | -9.66%46.86M | -10.51%48.01M | -2.43%51.31M | -7.62%84.84M | -7.62%84.84M |
| -Accumulated depreciation | ---- | ---- | ---- | 34.27%-21.58M | 34.27%-21.58M | ---- | ---- | ---- | 14.69%-32.84M | 14.69%-32.84M |
| Investments and advances | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -80.05%18.78M | ---- | ---- |
| Other non current assets | -1.24%202.5M | -1.87%202.77M | -2.03%202.93M | 0.58%203.1M | 0.58%203.1M | 2.57%205.04M | 4,892.05%206.62M | 5,039.68%207.13M | 4,867.65%201.94M | 4,867.65%201.94M |
| Total non current assets | -4.87%239.63M | -4.68%242.72M | -10.89%247.01M | -2.16%248.46M | -2.16%248.46M | 0.05%251.9M | 23.59%254.63M | 83.92%277.21M | 103.23%253.94M | 103.23%253.94M |
| Total assets | -13.90%356.11M | -18.94%362.03M | -31.05%371.31M | -37.11%382M | -37.11%382M | -45.83%413.59M | 23.80%446.63M | 51.55%538.55M | 62.05%607.4M | 62.05%607.4M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | ---- | 420.33%8.16M | 207.02%8.18M | 415.70%8.01M | 415.70%8.01M | -55.63%2.37M | -48.96%1.57M | 76.36%2.66M | -49.84%1.55M | -49.84%1.55M |
| -accounts payable | ---- | 6.69%1.67M | -36.69%1.69M | -1.93%1.52M | -1.93%1.52M | -55.63%2.37M | -48.96%1.57M | 76.36%2.66M | -49.84%1.55M | -49.84%1.55M |
| -Other payable | ---- | --6.49M | --6.49M | --6.49M | --6.49M | ---- | ---- | ---- | ---- | ---- |
| Current accrued expenses | ---- | -23.42%10.56M | -41.35%9.42M | -37.13%12.83M | -37.13%12.83M | -14.59%13.26M | -48.73%13.79M | -45.59%16.07M | -46.22%20.41M | -46.22%20.41M |
| Current debt and capital lease obligation | ---- | -53.94%4.22M | -45.32%4.06M | -41.91%3.92M | -41.91%3.92M | 1,303.61%9.71M | 249.09%9.16M | -43.13%7.43M | -61.29%6.75M | -61.29%6.75M |
| -Current capital lease obligation | ---- | -53.94%4.22M | -45.32%4.06M | -41.91%3.92M | -41.91%3.92M | 1,303.61%9.71M | 249.09%9.16M | 83.30%7.43M | 1,242.54%6.75M | 1,242.54%6.75M |
| Current deferred liabilities | ---- | ---- | ---- | ---- | ---- | 0.00%24K | 0.00%24K | -75.51%24K | ---- | ---- |
| Current liabilities | -7.62%23.44M | -6.52%22.95M | -17.27%21.66M | -13.75%24.77M | -13.75%24.77M | -82.15%25.37M | -24.76%24.55M | -40.76%26.18M | -50.99%28.72M | -50.99%28.72M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -0.81%40.79M | -0.19%42.44M | 0.18%43.84M | -0.38%45.24M | -0.38%45.24M | -19.97%41.12M | -93.70%42.52M | -93.37%43.76M | -93.04%45.41M | -93.04%45.41M |
| -Long term capital lease obligation | -0.81%40.79M | -0.19%42.44M | 0.18%43.84M | -0.38%45.24M | -0.38%45.24M | -19.97%41.12M | -16.04%42.52M | -7.70%43.76M | -13.81%45.41M | -13.81%45.41M |
| Non current deferred liabilities | ---- | ---- | ---- | --0 | --0 | -12.06%175K | -11.27%181K | -37.87%187K | -38.06%192K | -38.06%192K |
| Other non current liabilities | -0.51%34.67M | -0.84%33.95M | 0.58%33.86M | 24.40%33.71M | 24.40%33.71M | 31.26%34.84M | 1,324.04%34.23M | 1,286.57%33.67M | 1,142.89%27.1M | 1,142.89%27.1M |
| Total non current liabilities | 3.47%147.02M | 2.45%145.39M | 2.09%144.78M | 5.37%144.24M | 5.37%144.24M | 0.93%142.09M | -79.07%141.92M | -78.60%141.81M | -79.10%136.89M | -79.10%136.89M |
| Total liabilities | 1.79%170.45M | 1.12%168.34M | -0.92%166.44M | 2.06%169M | 2.06%169M | -40.81%167.46M | -76.57%166.47M | -76.23%167.99M | -76.79%165.6M | -76.79%165.6M |
| Shareholders'equity | ||||||||||
| Share capital | ---- | --0 | --0 | --0 | --0 | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K |
| -common stock | ---- | --0 | --0 | --0 | --0 | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K | 0.00%1K |
| -Preferred stock | ---- | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | ---- | -5.12%-937.3M | -5.11%-920.77M | -6.46%-909.1M | -6.46%-909.1M | -6.76%-900.59M | 49.34%-891.64M | 50.00%-876M | 50.53%-853.91M | 50.53%-853.91M |
| Paid-in capital | ---- | -3.51%1.13B | -9.69%1.13B | -13.39%1.12B | -13.39%1.12B | -13.39%1.15B | -16.90%1.17B | -11.00%1.25B | -6.61%1.3B | -6.61%1.3B |
| Gains losses not affecting retained earnings | ---- | 92.31%-22K | -180.39%-41K | -333.33%-65K | -333.33%-65K | -85.95%-225K | -535.56%-286K | 282.14%51K | ---15K | ---15K |
| Total stockholders'equity | -24.57%185.65M | -30.87%193.69M | -44.71%204.87M | -51.79%213M | -51.79%213M | -48.78%246.13M | 180.09%280.16M | 205.44%370.56M | 230.49%441.8M | 230.49%441.8M |
| Total equity | -24.57%185.65M | -30.87%193.69M | -44.71%204.87M | -51.79%213M | -51.79%213M | -48.78%246.13M | 180.09%280.16M | 205.44%370.56M | 230.49%441.8M | 230.49%441.8M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data